Life Science Company News

Reset
Results 341 - 360 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17 18  19  20  21  22  23  24  25 »

CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clinical Data Update on May 8, 2024

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  CytomX Therapeutics, Inc.

Auron Announces Oral Presentation on Preclinical Data from Proprietary AURIGIN™ Platform at the AI in Biomedicine Keystone Symposia

Read more ››
By: GlobeNewswire - 01 May 2024

VYNE Therapeutics Announces Oral Presentations for VYN201 at the 2024 Society for Investigative Dermatology (SID) Annual Meeting

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  VYNE Therapeutics Inc.

Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 8

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Avadel Pharmaceuticals plc

The Canadian Dermatology Association urges Canadians to protect themselves from skin cancer this summer

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Canadian Dermatology Association

Creyon Bio and Cajal Neuroscience Announce Partnership to Develop Oligonucleotide-Based Medicines for Neurodegenerative Diseases

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Creyon Bio, Inc.

Busy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree Story

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Supernus Pharmaceuticals, Inc.

Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity

Read more ››
By: GlobeNewswire - 01 May 2024

Goodness Growth Provides CREAM & Fire Updates

Read more ››
By: GlobeNewswire - 01 May 2024

Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Akari Therapeutics Plc

electroCore to Announce First Quarter March 31, 2024 Financial Results on Wednesday, May 8, 2024

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  electroCore, Inc.

Tevogen Bio Announces Full Year 2023 Financial Results and Upcoming Operational Objectives

Read more ››
By: GlobeNewswire - 01 May 2024

Yield10 Bioscience Announces 1-for-24 Reverse Stock Split

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Yield10 Bioscience, Inc.

Alpha Tau to Participate in May Investor Conferences

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Alpha Tau Medical Ltd.

Palisade Bio’s Lead Product Candidate, PALI-2108 Demonstrates Potent Anti-Inflammatory Effects in Ex-Vivo Study of Whole Blood Samples Challenged with Pro-Inflammatory Lipopolysaccharide (LPS)

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Palisade Bio, Inc.

Aileron Therapeutics Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Aileron Therapeutics, Inc.

Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Veru Inc.

Novo Nordisk A/S - share repurchase programme

Read more ››
By: GlobeNewswire - 01 May 2024

NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  Neuronetics, Inc.

SELLAS Announces Positive Phase 2 Preliminary Data of SLS009 in r/r AML Achieving a 100% Response Rate in Patients with ASXL1 Mutation At the Optimal Dose Level

Read more ››
By: GlobeNewswire - 01 May 2024
Related companies:  SELLAS Life Sciences Group, Inc.
Results 341 - 360 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17 18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »